JPMorgan Chase & Co’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,298,822
| Closed | -$3.95M | – | 6682 |
|
2024
Q4 | $3.95M | Buy |
1,298,822
+1,164,641
| +868% | +$3.54M | ﹤0.01% | 2933 |
|
2024
Q3 | $696K | Sell |
134,181
-2,810,680
| -95% | -$14.6M | ﹤0.01% | 3850 |
|
2024
Q2 | $7.57M | Sell |
2,944,861
-208,262
| -7% | -$535K | ﹤0.01% | 2280 |
|
2024
Q1 | $15.5M | Sell |
3,153,123
-1,490,296
| -32% | -$7.33M | ﹤0.01% | 1849 |
|
2023
Q4 | $40.8M | Buy |
4,643,419
+13,222
| +0.3% | +$116K | ﹤0.01% | 1201 |
|
2023
Q3 | $53.1M | Sell |
4,630,197
-63,691
| -1% | -$731K | 0.01% | 989 |
|
2023
Q2 | $119M | Sell |
4,693,888
-470,269
| -9% | -$11.9M | 0.01% | 704 |
|
2023
Q1 | $166M | Buy |
5,164,157
+149,735
| +3% | +$4.82M | 0.02% | 559 |
|
2022
Q4 | $92.6M | Sell |
5,014,422
-436,076
| -8% | -$8.05M | 0.01% | 733 |
|
2022
Q3 | $147M | Sell |
5,450,498
-1,237,427
| -19% | -$33.4M | 0.02% | 546 |
|
2022
Q2 | $92.4M | Sell |
6,687,925
-129,280
| -2% | -$1.79M | 0.01% | 731 |
|
2022
Q1 | $133M | Sell |
6,817,205
-109,201
| -2% | -$2.13M | 0.02% | 678 |
|
2021
Q4 | $113M | Buy |
6,926,406
+1,844,101
| +36% | +$30.1M | 0.01% | 765 |
|
2021
Q3 | $142M | Buy |
5,082,305
+38,734
| +0.8% | +$1.08M | 0.02% | 661 |
|
2021
Q2 | $149M | Buy |
5,043,571
+609,745
| +14% | +$18.1M | 0.02% | 668 |
|
2021
Q1 | $124M | Buy |
4,433,826
+107,773
| +2% | +$3.01M | 0.02% | 704 |
|
2020
Q4 | $123M | Buy |
4,326,053
+246,997
| +6% | +$7M | 0.02% | 657 |
|
2020
Q3 | $105M | Buy |
4,079,056
+51,282
| +1% | +$1.32M | 0.02% | 632 |
|
2020
Q2 | $98.4M | Buy |
4,027,774
+113,176
| +3% | +$2.76M | 0.02% | 627 |
|
2020
Q1 | $57.9M | Sell |
3,914,598
-109,559
| -3% | -$1.62M | 0.01% | 707 |
|
2019
Q4 | $65.3M | Buy |
4,024,157
+1,369,385
| +52% | +$22.2M | 0.01% | 759 |
|
2019
Q3 | $34.5M | Buy |
2,654,772
+179,869
| +7% | +$2.34M | 0.01% | 1043 |
|
2019
Q2 | $31.3M | Sell |
2,474,903
-1,422,967
| -37% | -$18M | 0.01% | 1103 |
|
2019
Q1 | $61.4M | Buy |
3,897,870
+92,811
| +2% | +$1.46M | 0.01% | 788 |
|
2018
Q4 | $76.6M | Buy |
3,805,059
+158,448
| +4% | +$3.19M | 0.02% | 658 |
|
2018
Q3 | $90.6M | Sell |
3,646,611
-18,836
| -0.5% | -$468K | 0.02% | 690 |
|
2018
Q2 | $101M | Buy |
3,665,447
+228,030
| +7% | +$6.26M | 0.02% | 610 |
|
2018
Q1 | $106M | Sell |
3,437,417
-120,562
| -3% | -$3.71M | 0.02% | 571 |
|
2017
Q4 | $127M | Buy |
3,557,979
+11,712
| +0.3% | +$419K | 0.03% | 510 |
|
2017
Q3 | $96.6M | Sell |
3,546,267
-80,336
| -2% | -$2.19M | 0.02% | 600 |
|
2017
Q2 | $95.7M | Buy |
3,626,603
+166,759
| +5% | +$4.4M | 0.02% | 595 |
|
2017
Q1 | $72M | Buy |
3,459,844
+29,686
| +0.9% | +$617K | 0.02% | 691 |
|
2016
Q4 | $71M | Buy |
3,430,158
+162,457
| +5% | +$3.36M | 0.02% | 657 |
|
2016
Q3 | $53M | Sell |
3,267,701
-59,321
| -2% | -$962K | 0.01% | 733 |
|
2016
Q2 | $45.2M | Buy |
3,327,022
+298,448
| +10% | +$4.06M | 0.01% | 798 |
|
2016
Q1 | $52.9M | Buy |
3,028,574
+94,432
| +3% | +$1.65M | 0.01% | 713 |
|
2015
Q4 | $100M | Buy |
2,934,142
+1,539,363
| +110% | +$52.6M | 0.03% | 520 |
|
2015
Q3 | $41.5M | Sell |
1,394,779
-1,726
| -0.1% | -$51.4K | 0.01% | 805 |
|
2015
Q2 | $44.7M | Buy |
1,396,505
+171,942
| +14% | +$5.5M | 0.01% | 868 |
|
2015
Q1 | $25.4M | Buy |
1,224,563
+502,287
| +70% | +$10.4M | 0.01% | 1174 |
|
2014
Q4 | $12.2M | Sell |
722,276
-68,541
| -9% | -$1.16M | ﹤0.01% | 1572 |
|
2014
Q3 | $15.3M | Buy |
790,817
+115,219
| +17% | +$2.23M | ﹤0.01% | 1419 |
|
2014
Q2 | $23M | Buy |
675,598
+406,398
| +151% | +$13.8M | 0.01% | 1233 |
|
2014
Q1 | $8.48M | Buy |
+269,200
| New | +$8.48M | ﹤0.01% | 1773 |
|